YDMI
PFE icon

Y.D. More Investments’s Pfizer PFE Stock Holding History

Y.D. More Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$793K Buy
32,930
+215
+0.7% +$5.62K 0.02% 138
2026
Q1 		$919K Sell
32,715
-17,444
-35% -$464K 0.04% 115
2025
Q4 		$1.25M Buy
50,159
+27,738
+124% +$699K 0.06% 115
2025
Q3 		$571K Buy
22,421
+393
+2% +$9.7K 0.03% 147
2025
Q2 		$534K Buy
22,028
+1,628
+8% +$38K 0.04% 145
2025
Q1 		$517K Sell
20,400
-12,907
-39% -$338K 0.05% 144
2024
Q4 		$884K Buy
33,307
+7,602
+30% +$206K 0.08% 117
2024
Q3 		$744K Sell
25,705
-32,919
-56% -$960K 0.08% 122
2024
Q2 		$1.64M Buy
58,624
+4,544
+8% +$125K 0.17% 80
2024
Q1 		$1.5M Sell
54,080
-792,535
-94% -$22M 0.27% 72
2023
Q4 		$24.4M Sell
846,615
-16,528
-2% -$500K 4.68% 4
2023
Q3 		$28.6M Sell
863,143
-43,379
-5% -$1.53M 5.5% 3
2023
Q2 		$33.3M Sell
906,522
-67,612
-7% -$2.63M 7.67% 1
2023
Q1 		$39.7M Buy
974,134
+656,059
+206% +$28.3M 8.96% 2
2022
Q4 		$16.3M Buy
+318,075
New +$15.2M 3.96% 6

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Y.D. More Investments's PFE Position: Q2 2026 in Review

Y.D. More Investments increased its Pfizer (PFE) stake by 0.66% in Q2 2026, buying an estimated $5.62K and bringing the position to 32,930 shares worth $793K. The position accounts for 0.02% of the portfolio, ranked #138.

Y.D. More Investments first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $39.7M in Q1 2023. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Y.D. More Investments held 32,930 shares of Pfizer worth $793K as of Q2 2026.
  • Y.D. More Investments bought 215 Pfizer shares in Q2 2026, an estimated $5.62K.
  • Pfizer made up 0.02% of Y.D. More Investments's portfolio in Q2 2026, its #138 holding.
  • Y.D. More Investments first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Y.D. More Investments's Pfizer position peaked at $39.7M in Q1 2023.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Y.D. More Investments's 13F filing for Q2 2026, filed 5 Aug 2026.